(Q42452773)

31 October 2017

title

The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome (English)

1 reference

31 October 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.7.X

1 April 2024

author name string

F. Lacarrubba

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616807

1 April 2024

R. De Pasquale

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616807

1 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14616807

1 April 2024

publication date

1 November 2003

1 reference

full work available at URL

31 October 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2230.28.s1.7.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.7.X

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2230.28.s1.7.x/fullpdf

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.7.X

Clinical and Experimental Dermatology

1 April 2024

published in

1 reference

31 October 2017

volume

28 Suppl 1

1 reference

31 October 2017

page(s)

19-23

1 reference

Pathological variants of basal cell carcinoma

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.7.X

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.7.X

Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.7.X

Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.7.X

Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.7.X

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.7.X

Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.7.X

Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.7.X

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.7.X

The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.7.X

Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.7.X

Nevoid basal cell carcinoma syndrome

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.7.X

Guidelines of care for basal cell carcinoma. The American Academy of Dermatology Committee on Guidelines of Care

1 April 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.7.X

Different treatment modalities for the management of a patient with the nevoid basal cell carcinoma syndrome

1 April 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.7.X

1 April 2024

Nonmelanoma skin cancer

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.7.X

Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream

1 April 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.7.X

1 April 2024

Identifiers

1 reference

31 October 2017

1 reference